Partner Investment Management’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-10,072
Closed -$141K 104
2018
Q4
$141K Hold
10,072
0.18% 70
2018
Q3
$176K Sell
10,072
-188
-2% -$3.6K 0.13% 97
2018
Q2
$187K Sell
10,260
-958
-9% -$16.2K 0.15% 96
2018
Q1
$210K Sell
11,218
-7,372
-40% -$144K 0.23% 76
2017
Q4
$284K Sell
18,590
-7,127
-28% -$105K 0.33% 63
2017
Q3
$384K Buy
25,717
+2,921
+13% +$27.4K 0.36% 66
2017
Q2
$212K Sell
22,796
-694
-3% -$6.32K 0.28% 71
2017
Q1
$207K Sell
23,490
-120
-0.5% -$880 0.25% 84
2016
Q4
$139K Sell
23,610
-36
-0.2% -$193 0.18% 84
2016
Q3
$148K Buy
23,646
+623
+3% +$3.16K 0.22% 77
2016
Q2
$62K Buy
23,023
+3,001
+15% +$9.33K 0.1% 74
2016
Q1
$81K Sell
20,022
-28,726
-59% -$136K 0.13% 78
2015
Q4
$409K Buy
+48,748
New +$384K 0.67% 46

Other funds holding KURA

Partner Investment Management's KURA Position: Q1 2019 in Review

Partner Investment Management sold out of Kura Oncology (KURA) in Q1 2019, closing a stake of 10,072 shares — an estimated $141K sold.

Partner Investment Management first reported a position in KURA in Q4 2015 and held it in 13 quarters. The position peaked at $409K in Q4 2015. 104 funds tracked by Wall St. Rank hold KURA as of Q1 2019.

  • Partner Investment Management reported no remaining Kura Oncology position as of Q1 2019 after selling out during the quarter.
  • Partner Investment Management sold 10,072 Kura Oncology shares in Q1 2019, an estimated $141K.
  • Partner Investment Management first reported a position in Kura Oncology in Q4 2015 and held it in 13 quarters.
  • Partner Investment Management's Kura Oncology position peaked at $409K in Q4 2015.
  • 104 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2019.

Based on Partner Investment Management's 13F filing for Q1 2019, filed 15 May 2019.